Download Sample
Add to CartGlobal Prostate Cancer Diagnostics & Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)
Segmented by Type;
Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma and Others.Segmented by Diagnosis;
Tissue Biopsy and Digital Rectal Examination - Transrectal Ultrasound and Transrectal Ultrasonography, Clinical Laboratory Examination - Prostate-Specific Antigen Testing, Urine Testing and Blood Testing, Diagnostic Imaging.Segmented by Treatment;
Chemotherapy, Brachytherapy and Radiation therapy.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).Introduction
Global Prostate Cancer Diagnostics & Therapeutics Market (USD Million), 2018 - 2028
| # | Global |
|---|---|
| 2018 | 72.9 |
| 2019 | 82.2 |
| 2020 | 98.5 |
| 2021 | 110.4 |
| 2022 | 113.1 |
| 2023 | 129.5 |
| 2024 | 131.6 |
| 2025 | 147.2 |
| 2026 | 174.7 |
| 2027 | 185.2 |
| 2028 | 216.9 |
In the year 2021, the Global Prostate Cancer Diagnostics & Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.
Global Prostate Cancer Diagnostics & Therapeutics Market Report Snapshot
| Parameters | Description |
|---|---|
| Market | Global Prostate Cancer Diagnostics & Therapeutics Market |
| Study Period | 2018 - 2028 |
| Base Year (for Prostate Cancer Diagnostics & Therapeutics Market Size Estimates) | 2021 |
| Study Scope |
|
| Market Segmentation |
|
| Geographical Coverage |
|
| Company Coverage |
|
| Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Prostate Cancer Diagnostics & Therapeutics Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Prostate Cancer Diagnostics & Therapeutics Market Analysis
In this report, the Global Prostate Cancer Diagnostics & Therapeutics Market has been segmented by Type, Diagnosis, Treatment and Geography.
Global Prostate Cancer Diagnostics & Therapeutics Market, Segmentation by Type
The Global Prostate Cancer Diagnostics & Therapeutics Market has been segmented by Type into Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma and Others. The complete Global Prostate Cancer Diagnostics & Therapeutics Market segmentation by Type can be seen below:
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Type
- Benign Prostatic Hyperplasia
- Prostatic Adenocarcinoma
- Small Cell Carcinoma
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Types mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Prostate Cancer Diagnostics & Therapeutics Market, by Type (USD Million), 2018 - 2028
| # | Benign Prostatic Hyperplasia | Prostatic Adenocarcinoma | Small Cell Carcinoma | Others |
|---|---|---|---|---|
| 2018 | 81.0 | 71.5 | 89.1 | 75.6 |
| 2019 | 90.7 | 82.5 | 102.3 | 76.7 |
| 2020 | 102.2 | 88.5 | 106.8 | 78.0 |
| 2021 | 111.6 | 93.4 | 123.7 | 91.1 |
| 2022 | 111.8 | 106.4 | 132.1 | 104.0 |
| 2023 | 125.2 | 106.5 | 144.4 | 112.7 |
| 2024 | 131.6 | 119.6 | 172.4 | 113.5 |
| 2025 | 144.6 | 130.3 | 201.5 | 136.1 |
| 2026 | 169.0 | 153.5 | 225.2 | 155.8 |
| 2027 | 193.6 | 169.5 | 246.0 | 176.3 |
| 2028 | 216.0 | 182.9 | 276.7 | 208.6 |
Global Prostate Cancer Diagnostics & Therapeutics Market, Segmentation by Diagnosis
The Global Prostate Cancer Diagnostics & Therapeutics Market has been segmented by Diagnosis into Tissue Biopsy, Digital Rectal Examination, Clinical Laboratory Examination and Diagnostic Imaging. The complete Global Prostate Cancer Diagnostics & Therapeutics Market segmentation by Diagnosis can be seen below:
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Diagnosis
- Tissue Biopsy
- Digital Rectal Examination
- Transrectal Ultrasound
- Transrectal Ultrasonography
- Clinical Laboratory Examination
- Prostate-Specific Antigen Testing
- Urine Testing
- Blood Testing
- Diagnostic Imaging
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Diagnosiss mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Diagnosis is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Prostate Cancer Diagnostics & Therapeutics Market, by Diagnosis (USD Million), 2018 - 2028
| # | Tissue Biopsy | Digital Rectal Examination | Clinical Laboratory Examination | Diagnostic Imaging |
|---|---|---|---|---|
| 2018 | 91.6 | 101.1 | 73.1 | 97.5 |
| 2019 | 99.7 | 116.5 | 81.6 | 103.9 |
| 2020 | 107.2 | 131.1 | 93.2 | 105.0 |
| 2021 | 118.6 | 145.9 | 103.9 | 113.9 |
| 2022 | 119.6 | 147.2 | 106.2 | 118.8 |
| 2023 | 128.7 | 149.5 | 119.1 | 118.8 |
| 2024 | 135.1 | 172.3 | 142.0 | 131.0 |
| 2025 | 152.9 | 188.0 | 155.5 | 134.5 |
| 2026 | 154.7 | 202.8 | 171.5 | 152.9 |
| 2027 | 167.7 | 223.5 | 201.7 | 181.2 |
| 2028 | 200.7 | 237.5 | 233.5 | 201.7 |
Global Prostate Cancer Diagnostics & Therapeutics Market, Segmentation by Treatment
The Global Prostate Cancer Diagnostics & Therapeutics Market has been segmented by Treatment into Chemotherapy, Brachytherapy and Radiation therapy. The complete Global Prostate Cancer Diagnostics & Therapeutics Market segmentation by Treatment can be seen below:
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Treatment
- Chemotherapy
- Brachytherapy
- Radiation therapy
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Treatments mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Treatment is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Prostate Cancer Diagnostics & Therapeutics Market, by Treatment (USD Million), 2018 - 2028
| # | Chemotherapy | Brachytherapy | Radiation therapy |
|---|---|---|---|
| 2018 | 71.6 | 111.8 | 64.5 |
| 2019 | 72.7 | 128.8 | 73.6 |
| 2020 | 78.0 | 152.3 | 74.5 |
| 2021 | 84.4 | 153.0 | 84.5 |
| 2022 | 96.2 | 179.5 | 100.5 |
| 2023 | 111.0 | 212.7 | 112.5 |
| 2024 | 130.1 | 236.8 | 115.4 |
| 2025 | 153.0 | 279.6 | 118.2 |
| 2026 | 180.8 | 293.6 | 120.2 |
| 2027 | 181.5 | 313.4 | 144.2 |
| 2028 | 202.4 | 348.4 | 165.1 |
Global Prostate Cancer Diagnostics & Therapeutics Market, Segmentation by Geography
In this report, the Global Prostate Cancer Diagnostics & Therapeutics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Prostate Cancer Diagnostics & Therapeutics Market Share (%), by Geographical Region, 2021
| North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
|---|---|---|---|---|
| 20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Prostate Cancer Diagnostics & Therapeutics Market in all the Regions and Countries (specified above) for historic (2018 - 2021) and forecast (2022 - 2028) Periods with 2021 considered as the base year.
This report also provides an analysis of why the market size of Prostate Cancer Diagnostics & Therapeutics in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Prostate Cancer Diagnostics & Therapeutics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Prostate Cancer Diagnostics & Therapeutics Market is driven by; High Disease Prevalence Rate of Prostate Cancer, Innovation in Drugs and Developments in Genomics and Proteomics, Rise in the Funding in Both Public and Private Sector in the Field of Drug Development and Technological Advancement in Oncology Diagnostics & Therapeutics Area.
- While the growth of Global Prostate Cancer Diagnostics & Therapeutics Market is currently hindered by; High Cost Associated with Diagnostic Tests, Low Success Rate of Clinical Trials and Side Effects of Treatments.
- The new opportunities in Global Prostate Cancer Diagnostics & Therapeutics Market will be discussed in detail in the full report.
- High Disease Prevalence Rate of Prostate Cancer.
- Innovation in Drugs and Developments in Genomics and Proteomics.
- Rise in the Funding in Both Public and Private Sector in the Field of Drug Development.
- Technological Advancement in Oncology Diagnostics & Therapeutics Area.
- High Cost Associated with Diagnostic Tests.
- Low Success Rate of Clinical Trials.
- Side Effects of Treatments.
- Global Prostate Cancer Diagnostics & Therapeutics Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Prostate Cancer Diagnostics & Therapeutics Market. The opportunity map (by market segments; Type, Diagnosis and Treatment) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Prostate Cancer Diagnostics & Therapeutics Market, Opportunity Map, By Region (2018 - 2028)
| North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
|---|---|---|---|---|
| 20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Prostate Cancer Diagnostics & Therapeutics Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Prostate Cancer Diagnostics & Therapeutics Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Prostate Cancer Diagnostics & Therapeutics Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Zytiga (abiraterone), approved for use in prostate cancer, is its biggest selling cancer drug, and saw sales jump 45.5% compared with last year's Q4 to $xxx million. What is Casodex? Casodex et decapeptyl (bicalutamide) is an anti-androgen. It works in the body by preventing the actions of androgens (male hormones). Casodex is used together with another hormone to treat prostate cancer. Casodex may also be used for prostate pill report purposes not listed in this medication guide. Important information. Casodex is used to treat prostate cancer. Lupron Depot triggers a receptor called the luteinizing hormone-releasing hormone (LHRH) receptor, lupron drug class, prostate cancer pipeline which results in an initial surge in testosterone. Xtandi's other competitors in the prostate cancer space include Bristol-Myers Squibb's Yervoy and Sanofi's Jevtana. Industry-specific factors such as pricing pressure, pipeline approval. The effects of the nonsteroidal antiandrogen bicalutamide (Casodex(TM)) and the luteinizing hormone releasing hormone agonist leuprolide depot (Procren Depot(TM), Lupron Depot(TM)) on serum prostate-specific antigen , cancer diagnostics (PSA), acid phosphatase (ACP), and prostatic acid phosphatase (PAP) in patients with benign prostatic hyperplasia (BPH) were lupron therapy prostate cancer determined.
Bargaining Power of Suppliers
| Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
|---|---|---|---|---|
| 20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Prostate Cancer Diagnostics & Therapeutics Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
| Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
|---|---|---|---|---|
| 10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Prostate Cancer Diagnostics & Therapeutics Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
| Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
|---|---|---|---|---|
| 20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Prostate Cancer Diagnostics & Therapeutics Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
| Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
|---|---|---|---|---|---|
| 2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Prostate Cancer Diagnostics & Therapeutics Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
| Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
|---|---|---|---|---|
| 5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Prostate Cancer Diagnostics & Therapeutics Market include, Abbott, AstraZeneca, Astellas Pharma Inc, Bayer AG, BioMark Diagnostics Inc., Sanofi, Ipsen, TOLMAR Pharmaceuticals, Inc., Indevus Pharmaceuticals Inc. and Dendreon Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
| Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product 1/Service 1 | ||||||||||
| Product 2/Service 2 | ||||||||||
| Product 3/Service 3 | ||||||||||
| Product 4/Service 4 | ||||||||||
| Product 5/Service 5 | ||||||||||
| Product 6/Service 6 | ||||||||||
| Product 7/Service 7 | ||||||||||
| Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Diagnosis
- Market Snapshot, By Treatment
- Market Snapshot, By Region
- Market Opportunity Map
- Global Prostate Cancer Diagnostics & Therapeutics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- High Disease Prevalence Rate of Prostate Cancer
- Innovation in Drugs and Developments in Genomics and Proteomics
- Rise in the Funding in Both Public and Private Sector in the Field of Drug Development
- Technological Advancement in Oncology Diagnostics & Therapeutics Area
- Restraints
- High Cost Associated with Diagnostic Tests
- Low Success Rate of Clinical Trials
- Side Effects of Treatments
- Opportunities
- Drivers
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Type, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Benign Prostatic Hyperplasia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Prostatic Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Small Cell Carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Benign Prostatic Hyperplasia
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Diagnosis, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Tissue Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Digital Rectal Examination
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Transrectal Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Transrectal Ultrasonography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Transrectal Ultrasound
- Clinical Laboratory Examination
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Prostate-Specific Antigen Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Urine Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Blood Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Prostate-Specific Antigen Testing
- Diagnostic Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Tissue Biopsy
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Treatment, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Brachytherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Radiation therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Chemotherapy
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Geography, 2018 - 2028 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2018 - 2028 (USD Million)
- Brazil
- North America
- Global Prostate Cancer Diagnostics & Therapeutics Market, By Type, 2018 - 2028 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Abbott
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AstraZeneca
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Astellas Pharma Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bayer AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- BioMark Diagnostics Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Sanofi
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Ipsen
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- TOLMAR Pharmaceuticals, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Indevus Pharmaceuticals Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Dendreon Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbott
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2021, the Global Prostate Cancer Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Prosthetic Heart Valves Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Prosthetics and Orthotics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Protein Assays Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%